Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Share-based Compensation (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Share-based Compensation for 2 consecutive years, with $518000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Share-based Compensation fell 85.7% to $518000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $3.0 million, a 77.76% decrease, with the full-year FY2024 number at $6.4 million, up 373.94% from a year prior.
  • Share-based Compensation was $518000.0 for Q4 2023 at LENZ Therapeutics, down from $2.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.6 million in Q4 2022 to a low of $142000.0 in Q1 2023.